Volume | 607,514 |
|
|||||
News | - | ||||||
Day High | 27.46 | Low High |
|||||
Day Low | 26.26 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Arcturus Therapeutics Holdings Inc | ARCT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
27.46 | 26.26 | 27.46 | 26.32 | 27.64 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
9,455 | 607,514 | $ 26.87 | $ 16,326,352 | - | 17.52 - 43.81 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:20:00 | formt | 304 | $ 26.32 | USD |
Arcturus Therapeutics (ARCT) Options Flow Summary
Arcturus Therapeutics Holdings Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
708.68M | 26.92M | - | 166.8M | -29.73M | -1.10 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Arcturus Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ARCT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 32.32 | 33.11 | 26.26 | 29.89 | 513,685 | -6.00 | -18.56% |
1 Month | 33.42 | 35.675 | 26.26 | 31.90 | 528,944 | -7.10 | -21.24% |
3 Months | 32.69 | 43.81 | 26.26 | 35.25 | 485,194 | -6.37 | -19.49% |
6 Months | 22.04 | 43.81 | 17.52 | 30.43 | 449,175 | 4.28 | 19.42% |
1 Year | 27.80 | 43.81 | 17.52 | 29.74 | 432,403 | -1.48 | -5.32% |
3 Years | 40.38 | 64.9735 | 11.70 | 29.21 | 538,615 | -14.06 | -34.82% |
5 Years | 7.50 | 129.71 | 5.70 | 39.15 | 556,000 | 18.82 | 250.93% |
Arcturus Therapeutics Description
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-COV19. |